Targeting Prognostic Proinflammatory Biomarkers to Improve Outcome on IO Drugs

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2019-000557
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

On the Article “Drugs Targeting Protease-Activated Receptor-4 Improve the Anti-Thrombotic Therapeutic Window”

Annals of Translational Medicine
Medicine
2018English

Insignement to Brain Targeting of Drugs

Drug Design Development and Delivery Journal
2018English

Targeting Tyrosine Hydroxylase to Improve Bradykinesia

2012English

Senescence: Adaptation to DNA Repair Targeting Drugs?

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2016English

Using Biomarkers to Improve Detection of Alzheimer’s Disease

Neurodegenerative disease management
MedicineNeurology
2011English

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Scientific Reports
Multidisciplinary
2013English

MS28.02 Combination IO+IO

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Novel Antisense Oligonucleotides Targeting TGF-β Inhibit in Vivo Scarring and Improve Surgical Outcome

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2003English

Targeting Enforcement to Improve Compliance With Environmental Regulations

Journal of Environmental Economics and Management
ManagementMonitoringEconomicsPolicyLawEconometrics
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy